|
Search
Collections
Benchmarks
Upload document
Product
SOT102
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
3 indications
Indication
Stomach Cancer
Indication
Pancreatic Cancer
Indication
Gastroesophageal junction cancer
Clinical trial
A Multicentric Phase 1/2 Trial to Evaluate the Safety and Efficacy of SOT102 as Monotherapy and in Combination With Standard of Care Treatment in Patients With Gastric and Pancreatic Adenocarcinoma
Status:
, Estimated PCD: 2023-12-01
